CIK: 1191235 - Address: C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD 20850
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113112-14-4-13-5
S%wins3333336710010061

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/22/24 16:33
5/20/24
MGNXMacrogenics IncDEHealthDrugPharmaceutical PreparationsStump David CMDDM.d00.0005New5D
7/26/12 09:00
7/24/12
HGSIHuman Genome Sciences IncDEHealthBioPrdBiological Products, (No DiagStump David CMDOExec. VPM.d4266.2006935188D
4/1/10 15:49
4/1/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPM.d42712.56333420D39399960-23-8-3-227-8-25-5-9
4/1/10 15:49
4/1/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPS.d-1,04430.7233-34-6320D39399960-23-8-3-227-8-25-5-9
3/2/10 13:15
3/1/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPM.d62812.56335020D38599957721624144-17-2-16
3/2/10 13:15
3/1/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPS.d-1,40428.0733-50-7220D38599957721624144-17-2-16
2/2/10 17:17
2/2/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPM.d62812.56335020D39499993381-9-1-2-1-8111-6-14
2/2/10 17:17
2/2/10
HGSIHuman Genome Sciences IncDEHealthDiagnIn Vitro & In Vivo DiagnosticStump David CMDOExec. VPS.d-1,37027.4033-50-7220D39499993381-9-1-2-1-8111-6-14

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact